AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
HQY

HealthEquity Inc. Common Stock (HQY) fair value

Healthcare · Health Information Services · NASDAQ · United States
$103.97+2.97%
Market cap $8.4BNext earnings 2026-12-02Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 22% above our fair value
Price
$103.97
Model fair valueConfidence: good
$85.01
Model range
$56.03 to $114
Fair value $85.01
Price $104
2 models fit HealthEquity Inc. Common Stock and they disagree: 0 of 2 land within 15% of the average.
Two or more of our models back this value.
Premium(i)Silver73
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionHealthEquity Inc. Common Stock (HQY)
Fair value (2 models)
$85.01
ACCE price target
$94.00
Rating
Overvalued
Horizon
12 months
Fair value published on 10 Oct 2026, 00:00 CEST; previously $87.96 since 6 Oct 2026, 00:00 CEST.
ACCE price target published on 10 Oct 2026, 00:00 CEST.
Price used: $104 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
22.3% above
-18.2% to fair value
ACCE score
66
out of 100
Analysts
100% buy
15 covering
P/E
35.3x
forward 19.7x
1-year return
+7.9%
Dividend yield
0.00%

HealthEquity Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

HealthEquity administers health savings accounts (HSAs) and related benefits, earning custodial and transaction fees on the assets it holds for employers and their employees. The moat is the platform itself: once an employer and its workforce are enrolled, switching custodians is costly and rare, and that stickiness shows up in a 71.2% gross margin and a 28.4% operating margin. Revenue growth of 7.6% is steady rather than explosive, and the forward P/E of 19.7 against a trailing 33.5 suggests the market expects earnings to catch up with that top line. At a $7.7B market cap with no index membership, the name sits in a space where coverage is thinner and mispricings can persist, which makes it worth a closer look at whether the margin profile is durable and how much of the earnings step-up the consensus has already priced in. ROE of 11.4% is the figure to pressure-test, since it is modest for a business with margins this high.

AI-assisted·How I use AIWritten Oct 18, 2026

Next results

Dec 2, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where HQY's valuation models land
Price
$103.97
Model fair value
$85.01
Model range
$56.03 to $114
Fair value $85.01
Price $104
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish100% buy · 15 covering analysts
● Strong buy 10● Buy 5● Hold 0● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
3 buys · 0 sells
Since May 29, 2026, 1 member
Average delay
15 days
From trade to public filing
Full trade list on ProDo politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+13.0%
1 month
+15.0%
3 months
+9.9%
6 months
+26.1%
YTD
+13.5%
1 year
+7.9%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 18:04 CESTRatingFairly valuedfirst publication$92.03
10 Oct 2026, 00:00 CESTFair value$85.23$87.96$93.05
10 Oct 2026, 00:00 CESTACCE price target$94.00first publication$93.05
6 Oct 2026, 00:00 CESTFair value$87.96$89.09$90.04
24 Sept 2026, 00:00 CESTFair value$89.09$90.70$91.75
21 Sept 2026, 00:00 CESTFair value$90.70$92.28$95.14
18 Sept 2026, 00:00 CESTFair value$92.28$93.29$96.00
13 Sept 2026, 00:00 CESTFair value$93.29$91.62$96.26
10 Sept 2026, 00:00 CESTFair value$91.62$93.79$93.36
31 Aug 2026, 00:00 CESTFair value$93.79$168$96.37

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full HQY page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth48Value55Quality78Momentum83Total66
Valuation
Trailing P/E
35.3x
Forward P/E
19.7x
PEG
1.32
P/B
3.76x
EV / Revenue
6.0x
Book value/sh
$24.00
Enterprise value
$8.2B
Profitability
ROE
11.4%
FCF yield
5.45%
ROIC
5.7%
Health and risk
Debt / equity
0.48
Dividend yield
0.00%
Beta
0.24

Price

+7.7% · 1Y

Ask anything about HQY

Answered from HealthEquity Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 67% of peers
low 0.0x35.3xhigh 54.6x
ROEbetter than 33% of peers
low -67%11%high 30%
Div yieldbetter than 83% of peers
low 0.0%0.0%high 1.1%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
HQY HealthEquity Inc. Common Stock$103.97$8522% above35.3x11.4%7866
2413.T M3, Inc.¥1934.50--28.2x12.0%7456
HNGE Hinge Health Inc. Class A Common Stock$109.93$16333% below36.3x30.4%9370
TEM Tempus AI Inc. Class A Common Stock$63.81----67.4%3341
DOCS Doximity Inc. Class A Common Stock$33.68$2917% above39.6x17.2%8657
BTSG BrightSpring Health Services Inc. Common Stock$60.86$3572% above54.6x13.0%4469
WAY Waystar Holding Corp. Common Stock$28.98$2421% above41.4x3.8%6667

Sector report card

Where HQY ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Sep 30, 2026
    HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors
  • GlobeNewswire•Aug 3, 2026
    HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule
  • GlobeNewswire•Jun 8, 2026
    One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds
40 filings
October 2026
Oct 19
Form 4Insider transactionPeriod 2026-04-22
View on SEC →
Oct 9
8-KCurrent reportPeriod 2026-10-05
View on SEC →
Oct 8
Form 4Insider transactionPeriod 2026-10-06
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR